Rutgers Launches Trial of Psoriasis Drug to Fight Deadly COVID-19 Complication
Rutgers is launching a trial of an experimental psoriasis drug that may also fight one of the deadliest complications of COVID-19, a condition that causes the immune system to attack the lungs and other organs.nbcNewYork
No comments:
Post a Comment